Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters

Acne Clinical Trials

A listing of Acne medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (4) clinical trials

A clinical trial to evaluate treatments for patients with Acne Vulgaris

Multi-center, prospective, open-label study utilizing before-after study design. Up to 20 healthy subjects, age 18 - 55 years with acne vulgaris who wish to improve their skin appearance will be randomized to receive either Diamondpolar applicator (radio frequency and pulsed magnetic field) treatment followed by AC Dual applicator (intense pulsed ...

Phase N/A

A clinical trial sponsored by Tufts Medical Center for a research study for the treatment of Hidradenitis Suppurativa

Secukinumab is an antibody that inhibits Interleukin-17A, and IL-17 promotes neutrophil activities. Neutrophils are found in large numbers in HS. The expression of the inflammatory cytokines IL-17, IL-1, and TNF- were enhanced in lesional skin of HS patients. Prior studies have demonstrated improvement in HS with biologic medications such as ...

Phase N/A

A clinical trial sponsored by Naked Biome, Inc. for a research study for the treatment of Acne Vulgaris

A Phase IB Dose Escalating Study of the Safety, Short-Term Engraftment and Action of a Singly Applied NB01 in Adults with Moderate Acne Acne vulgaris is a multifactorial disease caused by overgrowth of Propionibacterium acnes (P. acnes), impaction of hair follicles, excessive sebum production and hormonal dysregulation. Recent literature from ...


A clinical trial seeking patients for a research study for the treatment of Acne Vulgaris

This is a single-center, open label pilot study. The study is comprised of 5 study visits; Screening, Baseline, and weeks 4,8, and 12. All subjects will receive Oracea once daily (QD) and Epiduo Forte at Baseline. WE will evaluate Investigator Global Assessment (IGA), total lesion count, adverse events and concomitant ...